Zynerba Pharmaceuticals, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Leo To Pay $14m For Timber, Plus Milest

Les Laboratoires Servier and fellow French firm Neurochlore 's efforts to develop the common diuretic bumetanide as a treatment for the symptoms of autism have floundered after they unveiled disappoi

Japan’s Shionogi & Co. Ltd. has strengthened its existing links with research partner Tetra Therapeutics by increasing its ownership of the US-based venture to up to 50% through a new merger agree

With 45 biopharmaceutical company initial public offerings in the US this year through the end of July, including nine IPOs that month, 2018 has already surpassed 2017, when 42 drug developers went pu